Nasdaq Stockholm-listed diagnostic company Immunovia has named Philipp Mathieu as CEO and president following a search, instigated in December 2021, to replace exiting CEO Patrik Dahlen. Mathieu has been acting…
Nasdaq Stockholm-listed diagnostic company Immunovia has named Philipp Mathieu as CEO and president following a search, instigated in December 2021, to replace exiting CEO Patrik Dahlen. Mathieu has been acting…
…
Rankings & Reports
M&A
Equity
Healthcare Investing Review
Healthcare Real Assets Report
Resources & Events
Resource Hub
Sector Events
Private Capital Conference
Real Assets Conference


